Amgen to take the worst repatha reps to launch KRAS drug!

[anonymous]

No oncology experience needed as drug will sell itself

 

[anonymous]

No oncology experience needed as drug will sell itself

So all of those CV "overlay" reps that aren't needed will get a nice new shiny Oncology drug?? Great!

 

[anonymous]

So all of those CV "overlay" reps that aren't needed will get a nice new shiny Oncology drug?? Great!

Yes - the first in class KRAS drug AMG 510. It will be in pivotal studies soon based on a fast track break through designation that Amgen is banking on.

This drug will be so good reps just need to show up and it will sell like hot cakes.

Those bottom feeding reps will now hey higher bonuses and look like they are king.

 

[anonymous]

So all of those CV "overlay" reps that aren't needed will get a nice new shiny Oncology drug?? Great!

And then companies will poach then because they are onc reps while you are still viewed as a pcp rep. It ain’t fair huh

 

[anonymous]

Irrational exuberance!

 

[anonymous]

Yes - the first in class KRAS drug AMG 510. It will be in pivotal studies soon based on a fast track break through designation that Amgen is banking on.

This drug will be so good reps just need to show up and it will sell like hot cakes.

Those bottom feeding reps will now hey higher bonuses and look like they are king.

The Amgen Way.

 

[anonymous]

Considering how bad Repatha sales have been, is there such a thing as a good Repatha rep?

 

[anonymous]

JayChiang wants to be part of the KrAS program so he can use it as a testament to his leadership of white people and that he is successful

 

[anonymous]

The Amgen Way.

yup